Literature DB >> 26228625

Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait.

Marina Picillo1,2, Raffaele Dubbioso3, Rosa Iodice4, Alessandro Iavarone5, Chiara Pisciotta6, Emanuele Spina7, Lucio Santoro8, Paolo Barone9, Marianna Amboni10,11, Fiore Manganelli12.   

Abstract

Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson's disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG-). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG-. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG- had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG-. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.

Entities:  

Keywords:  Cholinergic activity; Cognition; Freezing; Gait; PPN; Parkinson's disease; SAI; TMS

Mesh:

Year:  2015        PMID: 26228625     DOI: 10.1007/s00702-015-1428-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

1.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

2.  Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.

Authors:  Nicolaas I Bohnen; Kirk A Frey; Stephanie Studenski; Vikas Kotagal; Robert A Koeppe; Gregory M Constantine; Peter J H Scott; Roger L Albin; Martijn L T M Müller
Journal:  Mov Disord       Date:  2014-06-07       Impact factor: 10.338

3.  Short latency afferent inhibition in Parkinson's disease patients with dementia.

Authors:  Ozlem Celebi; Cağrı Mesut Temuçin; Bulent Elibol; Esen Saka
Journal:  Mov Disord       Date:  2012-05-17       Impact factor: 10.338

4.  Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus.

Authors:  Timothy L Tattersall; Peter G Stratton; Terry J Coyne; Raymond Cook; Paul Silberstein; Peter A Silburn; François Windels; Pankaj Sah
Journal:  Nat Neurosci       Date:  2014-02-02       Impact factor: 24.884

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  Freezing of gait: moving forward on a mysterious clinical phenomenon.

Authors:  John G Nutt; Bastiaan R Bloem; Nir Giladi; Mark Hallett; Fay B Horak; Alice Nieuwboer
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

7.  Impairment of sensory-motor integration in patients affected by RLS.

Authors:  Vincenzo Rizzo; I Aricò; G Liotta; L Ricciardi; C Mastroeni; F Morgante; R Allegra; R Condurso; P Girlanda; R Silvestri; A Quartarone
Journal:  J Neurol       Date:  2010-07-16       Impact factor: 4.849

Review 8.  Pedunculopontine nucleus: functional organization and clinical implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2013-03-19       Impact factor: 9.910

Review 9.  Characterizing freezing of gait in Parkinson's disease: models of an episodic phenomenon.

Authors:  Alice Nieuwboer; Nir Giladi
Journal:  Mov Disord       Date:  2013-09-15       Impact factor: 10.338

10.  Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?

Authors:  Alison J Yarnall; Lynn Rochester; Mark R Baker; Rachel David; Tien K Khoo; Gordan W Duncan; Brook Galna; David J Burn
Journal:  Mov Disord       Date:  2013-02-28       Impact factor: 10.338

View more
  7 in total

Review 1.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

2.  Different cortical excitability profiles in hereditary brain iron and copper accumulation.

Authors:  Raffaele Dubbioso; Lucia Ruggiero; Marcello Esposito; Paola Tarantino; Marcello De Angelis; Francesco Aruta; Sabina Pappatà; Lorenzo Ugga; Alberto Piperno; Raffaele Iorio; Lucio Santoro; Rosa Iodice; Fiore Manganelli
Journal:  Neurol Sci       Date:  2019-11-26       Impact factor: 3.307

3.  Short-latency afferent inhibition determined by the sensory afferent volley.

Authors:  Aaron Z Bailey; Michael J Asmussen; Aimee J Nelson
Journal:  J Neurophysiol       Date:  2016-05-25       Impact factor: 2.714

Review 4.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

5.  In vivo evidence of cortical amyloid deposition in the adult form of Niemann Pick type C.

Authors:  Marcello Esposito; Raffaele Dubbioso; Stefano Tozza; Rosa Iodice; Marco Aiello; Emanuele Nicolai; Carlo Cavaliere; Marco Salvatore; Lucio Santoro; Fiore Manganelli
Journal:  Heliyon       Date:  2019-11-14

Review 6.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21

7.  Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease.

Authors:  Douglas N Martini; Rosie Morris; Valerie E Kelly; Amie Hiller; Kathryn A Chung; Shu-Ching Hu; Cyrus P Zabetian; John Oakley; Kathleen Poston; Ignacio F Mata; Karen L Edwards; Jodi A Lapidus; Thomas J Grabowski; Thomas J Montine; Joseph F Quinn; Fay Horak
Journal:  Front Neurol       Date:  2020-09-04       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.